Isovanillic acid protects mice against Staphylococcus aureus by targeting vWbp and Coa.

Our primary objective was to investigate the protective effects and mechanisms of isovanillic acid in mice infected with Newman. coagulation assays were used to validate vWbp and Coa as inhibitory targets of isovanillic acid. The binding mechanism of isovanillic acid to vWbp and Coa was investigated using molecular docking and point mutagenesis. Importantly, a lethal pneumonia mouse model was used to assess the effect of isovanillic acid on survival and pathological injury in mice. Isovanillic acid reduced the virulence of by directly binding to inhibit the clotting activity of vWbp and Coa, thereby reducing lung histopathological damage and improving the survival rate in mice with pneumonia.